Navigation Links
Abatacept as effective as adalimumab in rheumatoid arthritis
Date:6/12/2013

Madrid, Spain, 12 June 2013: Data from AMPLE presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate comparable efficacy and similar safety profiles between subcutaneous abatacept (ABA) and adalimumab (ADA).

AMPLE, the first two-year head-to-head biologics trial, was comprised of 646 biologic-nave patients with active rheumatoid arthritis (RA) equally randomised to either ABA or ADA, with a stable dose of methotrexate (MTX). 79.2% (252 of 318) ABA patients and 74.7% (245 of 328) ADA patients completed the trial.

RA is a chronic autoimmune disease that principally attacks flexible joints. Affecting approximately 1 in 100 people worldwide, RA can cause pain, stiffness, progressive joint destruction and deformity, and reduce physical function, quality of life and life expectancy. At least 50% of RA patients in developed countries are unable to hold down a full-time job within 10 years of onset.2

"To date, there have been no randomised, controlled studies directly comparing the efficacy and safety of different biological DMARDs using the combination of a biologic medication and methotrexate, the most commonly prescribed treatment approach in moderate to severe RA", said lead author of the study Dr. Michael Schiff, University of Colorado, USA.

"This robust data set demonstrates that subcutaneous abatacept and adalimumab are equally efficacious in clinical, functional and radiographic outcomes. This study is a great leap forward for patients as it shows another treatment is as effective as adalimumab" Dr. Schiff concluded.

AMPLE is a Phase IIIb randomised, investigator-blinded study with a primary efficacy endpoint at day 365. Biologic-nave patients with active RA and an inadequate response to MTX were randomized to 125 mg ABA weekly (without an IV load) or 40 mg ADA bi-weekly, with a stable dose of MTX. All clinical efficacy endpoints were captured and read through day 729, i
'/>"/>

Contact: EULAR Press Office
eularpressoffice@cohnwolfe.com
44-020-733-15364
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Head-to-head study in RA shows that abatacept has comparable efficacy to adalimumab
2. Daimer Offers Steam Cleaner Vacuums for Effective Restroom Cleaning in Commercial Settings
3. The Fight Against West Nile Virus Begins Again: Learn Simple, Effective Tips to Protect Yourself and Family
4. PET/MR effective for imaging recurrent prostate cancer
5. Rihanna Herpes and Lipstick Fiasco Shows Need for Effective Herpes Remedy; polyDNA Recommends Gene-Eden-VIR to Kill Latent Herpes Virus
6. Screening at-risk adolescents for celiac disease proves cost-effective
7. 2013 Report Confirms Effective Cyber Emergency Response Plan is Vital to Slash Data Breach Costs
8. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offer New, Advanced Weight Loss Tips to Rapidly Reduce Weight and Increase Effective Stress Management
9. Everyday Vitamin Nutrition LLC Offers Most Potent and Effective Garcinia Cambogia for Appetite Suppression
10. African Mango Plus is Clinically Proven Effective Formula to Increase the Energy Level of the Body
11. ZetaClear the 2-Step Natural Formula is Now Available to Effectively Fight Against the Nail Fungus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Altima Technologies, Inc., the maker of popular NetZoom ... data center assets and audio-video devices, recently released ... , Manufacturer / Device Model, EMC VMAX, Cisco ... Middle Atlantic Products RSH Series, Nokia Siemens Networks ... MM Series, Extron Electronics SW Series, Crestron Electronics ...
(Date:5/28/2015)... 28, 2015 Workers’ compensation costs per claim ... a recent study by the Workers Compensation Research Institute ... three-year period. , The WCRI study, CompScope™ Benchmarks for ... missed seven days or more of work with those of ... 2011 Michigan claim was 4 percent lower than similar claims ...
(Date:5/28/2015)... More than 300 locations of the Richmond-based company ... the Muscular Dystrophy Association save and improve the lives ... that limit muscle strength and mobility by participating in ... 1 to June 30, sweetFrog associates will sell $1 ... send local children affected by neuromuscular diseases to a ...
(Date:5/28/2015)... 2015 Healthpointe is proud to ... offering Echocardiography Examinations to patients with cardiovascular needs. ... Qualified Medical Examiner and licensed Cardiologist, Dr. Oscar ... a non-invasive and cost-effective approach to effectively diagnosing ... or have undergone surgery. Also known as ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
Breaking Medicine News(10 mins):Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2
... 21 (HealthDay News) -- No new patients will be ... controversial diabetes drug Avandia until further notice, the U.S. ... the partial clinical trial hold, those patients already enrolled ... trial will be allowed to continue to participate, the ...
... Hospitals Case Medical Center Center for AIDS Research ... renewal grant from the National Institutes of Health ... and technological support to researchers working on HIV-related ... Medical Center, MetroHealth Medical Center, Cleveland Clinic, and ...
... (HealthDay News) -- The cancer drug Avastin should no longer ... Food and Drug Administration advisory panel voted Tuesday, saying the ... represented a setback for Avastin, which is the world,s best-selling ... Avastin is sold by drug maker Roche,s Genentech unit, ...
... ,The Lancet Series on HIV in people ... at the International AIDS conference in Vienna, reports that ... injecting drug users (IDUs), health providers must focus less ... and more on conditions of health delivery that create ...
... Gay and bisexual men enrolled in a long-term study of ... experience psychosocial health problems later in life that could put ... Pittsburgh Graduate School of Public Health researchers at the ... more than 1,000 HIV-positive and negative gay and bisexual men ...
... By Kathleen Doheny HealthDay Reporter , TUESDAY, July ... older adults, meant to be humorous, shows a vulture on a ... might find the humor unsettling, the blunt message is right on ... is better than none, exercise experts say. Yet they also ...
Cached Medicine News:Health News:FDA Puts Partial Hold on Avandia Safety Study 2Health News:$9M NIH grant renewal awarded to Case Western Reserve/UHCMC Center for AIDS Research 2Health News:$9M NIH grant renewal awarded to Case Western Reserve/UHCMC Center for AIDS Research 3Health News:FDA Advisers Say Avastin Shouldn't Be Used for Breast Cancer 2Health News:Improved treatment access requires end to portrayal of drug abusers as already dead 2Health News:Improved treatment access requires end to portrayal of drug abusers as already dead 3Health News:'Get Moving' Can Be Vital Advice for Seniors 2Health News:'Get Moving' Can Be Vital Advice for Seniors 3
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 /PRNewswire/ ... a clinical-stage biopharmaceutical company leveraging its molecular adhesion ... therapies for sickle cell disease, heart failure, and ... be resigning from the Company,s Board of Directors. ... potential conflict of interest given his role as ...
(Date:5/28/2015)... 2015 Compassion & Choices today is pleased to ... that would authorize the option of medical aid in dying ... The legislation, the ... mentally competent adults with six months or less to live ... painlessly and peacefully end an unbearable dying process. A vote ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3
... http://www.omxgroup.com, OMX: DIAM B; ... http://www.otcqx.com, OTC: DMYDY), STOCKHOLM, ... that the Swedish Medical Products,Agency (MPA) has approved the Company,s ... Diamyd(R)., (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ), "I am ...
... Asthma and Exercise-Induced ... Bronchoconstriction -, PLYMOUTH MEETING, Pa., ... development partner,MedImmune, has initiated its fourth phase 2a clinical trial of ... This clinical trial is designed to assess the,potential of MEDI-528 in ...
Cached Medicine Technology:Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 2Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 3Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma 4
Instrument for transphenoidal hypophysectomy, bayonet-shaped, dissector, sharp inner edge, left....
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
... Triad Facet Screws ... a posterior tension band ... construct. Through utility of ... percutaneous placement of Triad ...
Cushing pituitary scoop, malleable, silver-plated....
Medicine Products: